HGS-ETR1, a fully human agonistic monoclonal antibody to the tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) in patients with advanced solid cancer: Results of a phase 1 trial.

被引：0
|
作者：
Hirte, HW
Hotte, SJ
Chen, EX
Siu, L
Le, LH
Lo, L
MacLean, M
Iacobucci, A
Fox, NL
Oza, AM
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Juravinski Canc Ctr, Hamilton, ON, Canada
[3] Human Genome Sci Inc, Rockville, MD USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9104S / 9104S
页数：1
相关论文
共 50 条
  • [41] Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice
    Mi, QS
    Ly, D
    Lamhamedi-Cherradi, SE
    Salojin, KV
    Zhou, L
    Grattan, M
    Meagher, C
    Zucker, P
    Chen, YH
    Nagle, J
    Taub, D
    Delovitch, TL
    DIABETES, 2003, 52 (08) : 1967 - 1975
  • [42] Tumor necrosis factor-related apoptosis-inducing ligand is a novel transcriptional target of runt-related transcription factor 1
    Yoshida, Tatsushi
    Yamasaki, Kenta
    Tadagaki, Kenjiro
    Kuwahara, Yasumichi
    Matsumoto, Akifumi
    Sofovic, Adem Ejub
    Kondo, Noriko
    Sakai, Toshiyuki
    Okuda, Tsukasa
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 60 (01)
  • [43] Regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by DJ-1 in thyroid cancer cells
    Zhang, Hai-Yan
    Wang, Hua-Qin
    Liu, Hai-Mei
    Guan, Yifu
    Du, Zhen-Xian
    ENDOCRINE-RELATED CANCER, 2008, 15 (02) : 535 - 544
  • [44] Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells
    Secchiero, P
    Mirandola, P
    Zella, D
    Celeghini, C
    Gonelli, A
    Vitale, M
    Capitani, S
    Zauli, G
    BLOOD, 2001, 98 (08) : 2474 - 2481
  • [45] Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
    Mom, Constantijne H.
    Verweij, Jaap
    Oldenhuis, Corina N. A. M.
    Gietema, Jourik A.
    Fox, Norma Lynn
    Miceli, Rene
    Eskens, Ferry A. L. M.
    Loos, Walter J.
    de Vries, Elisabeth G. E.
    Sleijfer, Stefan
    CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5584 - 5590
  • [46] Hypoxia inducing factor-1α regulates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in tumor cells exposed to hypoxia
    Jeong, Jae-Kyo
    Moon, Myung-Hee
    Seo, Jae-Suk
    Seol, Jae-Won
    Park, Sang-Youel
    Lee, You-Jin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 399 (03) : 379 - 383
  • [47] Bortezomib sensitizes non-Hodgkin's lymphoma cells to apoptosis induced by antibodies to tumor necrosis factor - Related apoptosis-inducing ligand (TRAIL) receptors TRAIL-R1 and TRAIL-R2
    Smith, Mitchell R.
    Jin, Fang
    Joshi, Indira
    CLINICAL CANCER RESEARCH, 2007, 13 (18) : 5528S - 5534S
  • [48] Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus
    Cheung, SSC
    Metzger, DL
    Wang, XJ
    Huang, JQ
    Tai, J
    Tingle, AJ
    Ou, DW
    PANCREAS, 2005, 30 (02) : 105 - 114
  • [49] RIP-1/c-FLIPL Induce Hepatic Cancer Cell Apoptosis Through Regulating Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)
    Sun, Jichun
    Yu, Xiao
    Wang, Changfa
    Yu, Can
    Li, Zhiqiang
    Nie, Wanpin
    Xu, Xundi
    Miao, Xiongying
    Jin, Xiaoxin
    MEDICAL SCIENCE MONITOR, 2017, 23 : 1190 - 1199
  • [50] Phase I and pharmacokinetic study of HGS-ETR2, a fully human agonistic monoclonal antibody to TRAIL-R2, in patients with advanced solid malignancies.
    Attard, G
    Plummer, RE
    De Bono, JS
    Bale, C
    Fong, P
    Barrett, M
    Fox, NL
    Howard, T
    Ullrich, S
    Calvert, H
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9060S - 9060S
12345